Dasanat 50 Dasatinib Tablets

Product Composition

• Indicated For: Chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL)
• Active Ingredient: Dasatinib 50mg
• Mechanism of Action: Inhibits tyrosine kinase to prevent cancer cell growth
• Dosage Form: Oral tablets (60 tablets per bottle)
• Manufactured By: Natco Pharma Ltd (WHO-GMP certified)
• Patient Benefits: Effective in resistant CML cases, improves survival rates
• Medical Supervision Required: Use under doctor’s prescription.
• Dasanat 50mg Tablet contains Dasatinib (50mg), a tyrosine kinase inhibitor (TKI) used in the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It works by blocking abnormal proteins that signal cancer cells to grow, thereby slowing or stopping cancer progression. Manufactured by Natco Pharma Ltd, this medication meets strict quality standards for efficacy and safety. Dasanat 50mg is prescribed for patients who are newly diagnosed or have shown resistance to prior treatments. It is available in a bottle of 60 tablets and should be taken under medical supervision to ensure optimal therapeutic benefits.